BLOOMSBURY, NJ —
OSHA Inspection: QUVA PHARMA, INC
Complaint inspection · Health discipline
At a glance
On , OSHA opened a complaint health inspection of QUVA PHARMA, INC in 519 STATE ROUTE 173, BLOOMSBURY, NJ 08804 (NAICS 325412). OSHA activity number 347582280.
OSHA opens inspections for many reasons — routine scheduling under a national or local emphasis program, an employee complaint or referral, or a follow-up after a reported injury. Opening or conducting an inspection is not itself an allegation or a finding that this employer broke any rule; any findings appear as the citations listed below, and citations can be contested, reduced, or withdrawn.
Where did this inspection happen?
- Establishment
- QUVA PHARMA, INC
- Site address
- 519 STATE ROUTE 173
- City
- BLOOMSBURY
- State
- NJ
- ZIP
- 08804
- Mailing
- 519 STATE ROUTE 173, BLOOMSBURY, NJ 08804
What kind of inspection was it?
- Inspection type
- Complaint (B)
- Scope
- Partial (B)
- Discipline
- Health
- Advance notice
- No
- Union status
- B
When did the case open and close?
- Opened
- Closing conference
- Case closed
- Last modified
- Data loaded
Establishment context
- NAICS code
- 325412
- Employees
- 570
- Ownership type
- A
Citations
6 citations on file for this inspection.
1910.134 C01
- Issued
- Dec 23, 2024
- Penalty
- Initial $11,524 · Current $11,524
1470
General-duty citation text
29 CFR 1910.134(c)(1): A written respiratory protection program that included the provisions in 29 CFR 1910.134(c)(1)(i) - (ix) with worksite specific procedures was not established and implemented for required respirator use: (a) QuVa Pharma, Inc 519 State Route 173 Bloomsbury, NJ 08804 prep room in Building 1 and 2 On or about June 27, 2024, and thereafter, employee(s) were provided and required to use Alpha ProTech N-95 Particulate Respirator during the wiping process of medical equipment such as Syringes and IV bags using STERI-PEROX wipes containing 6% hydrogen peroxide as part of their daily duties, for which the employer did not have a written program for administering the use of respiratory protection in the workplace. Employee(s) were exposed to health hazard(s), including inhalation of toxic/hazardous substances such as hydrogen peroxide, as well as cardio-respiratory impacts from using a tight-fitting, negative-pressure respirator.
Recent events (3)
- — F (S) $11524
- — C (S) $11524
- — Z (S) $11524
1910.134 E01
- Issued
- Dec 23, 2024
- Penalty
- Initial $0 · Current $0
1470
General-duty citation text
29 CFR 1910.134(e)(1): The employer did not provide a medical evaluation to determine the employee's ability to use a respirator, before the employee was fit tested or required to use the respirator in the workplace: (a) QuVa Pharma, Inc 519 State Route 173 Bloomsbury, NJ 08804 prep room in Building 1 and 2 On or about June 27, 2024, and thereafter, employee(s) were provided and required to use Alpha ProTech N-95 Particulate Respirator during the process of wiping of medical equipment such as Syringes and IV bags using STERI-PEROX 6% wipes containing 6% hydrogen peroxide as part of their daily duties for which the employer did not provide a medical evaluation for employees to determine their ability to use a respirator before requiring use. Employee(s) were exposed to health hazard(s), including inhalation of toxic / hazardous substances such as hydrogen peroxide, as well as cardio-respiratory impacts from using a tight-fitting, negative-pressure respirator.
Recent events (3)
- — F (S) $0
- — C (S) $0
- — Z (S) $0
1910.134 K
- Issued
- Dec 23, 2024
- Penalty
- Initial $0 · Current $0
1470
General-duty citation text
29 CFR 1910.134(k): The employer did not provide comprehensive, understandable training annually or more often if necessary: (a) QuVa Pharma, Inc 519 State Route 173 Bloomsbury, NJ 08804 prep room in Building 1 and 2 On or about June 27, 2024, and thereafter, employee(s) were provided and required to use Alpha ProTech N-95 Particulate Respirator during the process of wiping medical equipment such as Syringes and IV bags using STERI-PEROX wipes containing 6% hydrogen peroxide as part of their daily duties, for which the employer did not provide training on respirator inspection, use (including seal-check), maintenance and storage. OSHA conducted personal exposure monitoring for airborne hydrogen peroxide vapor on August 5, 2024, during manual wiping of medical equipment as part of normal daily activities for two employees in Building 1 and two employees in Building 2. In Building 1, during 337 minutes of sampling and 358 minutes of sampling, with zero exposure assumed for the balance of the 480-min work shift, their exposures were measured at 3.19 parts per million (ppm) and 2.19 ppm, respectively, as an 8-hour time-weighted average (TWA). These measured exposures represent 319 % and 219 % of the OSHA Permissible Exposure Limit (PEL) of 1 ppm as an 8-hour TWA, exposing employees to health hazard(s) of airborne hydrogen peroxide vapor. In Building 2, during 293 minutes of sampling and 216 minutes of sampling, with zero exposure assumed for the balance of the 480-min work shift, their exposures were measured at 7.22 parts per million (ppm) and 1.89 ppm, respectively, as an 8-hour time-weighted average (TWA). These measured exposures represent 722 % and 189 % of the OSHA Permissible Exposure Limit (PEL) of 1 ppm as an 8-hour TWA, exposing employees to health hazard(s) of airborne hydrogen peroxide vapor.
Recent events (3)
- — F (S) $0
- — C (S) $0
- — Z (S) $0
1910.134 D03 II
- Issued
- Dec 23, 2024
- Penalty
- Initial $13,828 · Current $13,828
1470
General-duty citation text
29 CFR 1910.134(d)(3)(ii): The employer did not provide a respirator that was appropriate for the chemical state and physical form of the contaminant: (a) QuVa Pharma, Inc 519 State Route 173 Bloomsbury, NJ 08804 prep room in Building 1 and 2 On or about June 27, 2024, and thereafter, employee(s) were provided and required to AlphaProTech N-95 Particulate Respirator during the wiping process of medical equipment such as Syringes and IV bags using STERI-PEROX 6% wipes containing 6% hydrogen peroxide as part of their daily duties which is not the appropriate respirator for the chemical and physical form of the contaminant. Note: The NIOSH Pocket Guide to Chemical Hazards recommends a supplied air respirator (APF=10) for hydrogen peroxide exposure (up to 10 parts per million (ppm)). OSHA conducted personal exposure monitoring for airborne hydrogen peroxide vapor on August 5, 2024, during manual wiping of medical equipment as part of normal daily activities for two employees in Building 1 and two employees in Building 2. In Building 1, during 337 minutes of sampling and 358 minutes of sampling, with zero exposure assumed for the balance of the 480-min work shift, their exposures were measured at 3.19 parts per million (ppm) and 2.19 ppm, respectively, as an 8-hour time-weighted average (TWA). These measured exposures represent 319 % and 219 % of the OSHA Permissible Exposure Limit (PEL) of 1 ppm as an 8-hour TWA, exposing employees to health hazard(s) of airborne hydrogen peroxide vapor. In Building 2, during 293 minutes of sampling and 216 minutes of sampling, with zero exposure assumed for the balance of the 480-min work shift, their exposures were measured at 7.22 parts per million (ppm) and 1.89 ppm, respectively, as an 8-hour time-weighted average (TWA). These measured exposures represent 722 % and 189 % of the OSHA Permissible Exposure Limit (PEL) of 1 ppm as an 8-hour TWA, exposing employees to health hazard(s) of airborne hydrogen peroxide vapor.
Recent events (3)
- — F (S) $13828
- — C (S) $13828
- — Z (S) $13828
1910.1000 A02
- Issued
- Dec 23, 2024
- Penalty
- Initial $138,273 · Current $42,148 Reduced
1470
General-duty citation text
29 CFR 1910.1000(a)(2): Employee(s) were exposed to an airborne concentration of hydrogen peroxide listed in Table Z-1 in excess of the 8-hour Time Weighted Average concentration of 1 ppm: (a) QuVa Pharma, Inc 519 State Route 173 Bloomsbury, NJ 08804 prep room in Building 1 and 2 On or about June 27, 2024, and thereafter, employee(s) using STERI-PEROX wipes containing 6% hydrogen peroxide to wipe down medical equipment, such as Syringes and IV bags as part of their daily duties, were exposed to an airborne concentration of hydrogen peroxide in excess of the 8-hour Time Weighted Average concentration of 1 ppm. OSHA conducted personal exposure monitoring for airborne hydrogen peroxide vapor on August 5, 2024, during manual wiping of medical equipment as part of normal daily activities for two employees in Building 1 and two employees in Building 2. In Building 1, during 337 minutes of sampling and 358 minutes of sampling, with zero exposure assumed for the balance of the 480-min work shift, their exposures were measured at 3.19 parts per million (ppm) and 2.19 ppm, respectively, as an 8-hour time-weighted average (TWA). These measured exposures represent 319 % and 219 % of the OSHA Permissible Exposure Limit (PEL) of 1 ppm as an 8-hour TWA, exposing employees to health hazard(s) of airborne hydrogen peroxide vapor. In Building 2, during 293 minutes of sampling and 216 minutes of sampling, with zero exposure assumed for the balance of the 480-min work shift, their exposures were measured at 7.22 parts per million (ppm) and 1.89 ppm, respectively, as an 8-hour time-weighted average (TWA). These measured exposures represent 722 % and 189 % of the OSHA Permissible Exposure Limit (PEL) of 1 ppm as an 8-hour TWA, exposing employees to health hazard(s) of airborne hydrogen peroxide vapor.
Recent events (3)
- — F (S) $42148
- — C (W) $138273
- — Z (W) $138273
1910.1000 E
- Issued
- Dec 23, 2024
- Penalty
- Initial $0 · Current $0
1470
General-duty citation text
29 CFR 1910.1000(e): Feasible administrative or engineering controls were not determined and implemented to achieve compliance with the limits prescribed in 29 CFR 1910.1000(a) through (d): (a) QuVa Pharma, Inc 519 State Route 173 Bloomsbury, NJ 08804 prep room in Building 1 and 2 On or about June 27, 2024, and thereafter, employee(s) used STERI-PEROX wipes containing 6% hydrogen peroxide to wipe down medical equipment, such as Syringes and IV bags as part of their daily duties, in prep room where feasible administrative or engineering controls were not determined and implemented to achieve compliance with the limits prescribed in 29 CFR 1910.1000(a) through (d). This exposed employees to an airborne concentration of hydrogen peroxide above the 8-hour Time Weighted Average concentration of 1 ppm. OSHA conducted personal exposure monitoring for airborne hydrogen peroxide vapor on August 5, 2024, during manual wiping of medical equipment as part of normal daily activities for two employees in Building 1 and two employees in Building 2. In Building 1, during 337 minutes of sampling and 358 minutes of sampling, with zero exposure assumed for the balance of the 480-min work shift, their exposures were measured at 3.19 parts per million (ppm) and 2.19 ppm, respectively, as an 8-hour time-weighted average (TWA). These measured exposures represent 319 % and 219 % of the OSHA Permissible Exposure Limit (PEL) of 1 ppm as an 8-hour TWA, exposing employees to health hazard(s) of airborne hydrogen peroxide vapor. In Building 2, during 293 minutes of sampling and 216 minutes of sampling, with zero exposure assumed for the balance of the 480-min work shift, their exposures were measured at 7.22 parts per million (ppm) and 1.89 ppm, respectively, as an 8-hour time-weighted average (TWA). These measured exposures represent 722 % and 189 % of the OSHA Permissible Exposure Limit (PEL) of 1 ppm as an 8-hour TWA, exposing employees to health hazard(s) of airborne hydrogen peroxide vapor.
Recent events (3)
- — F (S) $0
- — C (W) $0
- — Z (W) $0
More inspections at Quva Pharma, INC
View Quva Pharma, INC's full OSHA safety record →
More inspections in this industry (NAICS 325412)
More inspections in NJ
Source
This record is reproduced from the U.S. Department of Labor Open Data API (OSHA inspection dataset). The original IMIS detail view is available at OSHA's Establishment Search for activity number 347582280.
Look up any company's OSHA accident reports by company, or browse severe injury reports by year, state, and company.